FunPep Company Limited [4881.T]
TOKYO, Jun 25 (Pulse News Wire) – FunPep Company Limited (4881.T) reported extraordinary income of ¥1.2 million from a government grant received during the fiscal half-year ending June 30, 2026. The income stems from a subcontract agreement related to the genomic research program “Heart Failure Single Cell Genomics Drug Development,” which was awarded to the University of Tokyo by the Japan Agency for Medical Research and Development (AMED).
Previously recorded as prepaid revenue, the funds were reclassified as extraordinary income based on final verification results communicated by the University of Tokyo. This adjustment reflects the completion of the verification process for a portion of the transferred funds originally allocated for the fiscal year 2024 but carried forward to 2025.
🟢 Confidence: High AI-translated content.